Euromoney, is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023
Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Monetary policy: Argentina takes its bitter medicine

Another financial crisis has rocked the country. As it slips into what could be a deep recession, time is running out to achieve the recovery that could create the conditions for a pro-market candidate to win next year’s presidential elections.

medicine-argentina-lagarde_macri_-illo-780
Illustration: Jonathan Williams
 

IN ADDITION        


Gradualism is dead in Argentina. 

In its place a new strategy has been devised to tackle the country’s monetary and fiscal challenges. It has just begun to be implemented. 

But it is going to be a strong, inflation-fighting medicine with many serious and unavoidable side effects and a level of toxicity that may kill the administration’s ability to govern. 

The most obvious side effect will be a deep recession, already underway and that is expected to be lead to a contraction of around -2.5% this year. It will also drag on and likely lead to negative growth in 2019 – a presidential election year. 

Meanwhile the country’s banking sector is back in the survival stance it adopted under the previous president, Cristina Kirchner. 

As the recession hits and interest rates rise above 70%, the demand for credit has evaporated, with the exception of the distressed and the desperate.

Tags

Rob Dwyer head.jpg
Latin America editor
Rob Dwyer is Latin America editor. He has been a financial journalist since 1997 and has worked in London, New York and São Paulo, Brazil, where he is now based.